SKELMET - a German national consortium aimed at unravelling the biology of bone metastases
Skeletal metastases develop in up to 90% of malignancies and frequently cause pathological fractures and severe pain. Multimodal treatment of skeletal metastases is difficult and not causal, in part, because the underlying molecular pathogenesis is poorly understood.    learn more...
 
SKELMET members
 
Dresden: /project 3 /project 8     /Z project
Kiel: /project 7        
Würzburg: /project 5 /project 9      
associated projects: /project 1 /project 4 /project 6    
Technische Universitt Dresden    Christian-Albrechts-Universitt zu Kiel    Julius-Maximilians-Universitt Wrzburg
  © SKELMET. All Rights Reserved.  |   Legal Notice